1. Home
  2. CDNA vs RES Comparison

CDNA vs RES Comparison

Compare CDNA & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • RES
  • Stock Information
  • Founded
  • CDNA 1998
  • RES 1984
  • Country
  • CDNA United States
  • RES United States
  • Employees
  • CDNA N/A
  • RES N/A
  • Industry
  • CDNA Medical Specialities
  • RES Oilfield Services/Equipment
  • Sector
  • CDNA Health Care
  • RES Energy
  • Exchange
  • CDNA Nasdaq
  • RES Nasdaq
  • Market Cap
  • CDNA 1.1B
  • RES 1.3B
  • IPO Year
  • CDNA 2014
  • RES N/A
  • Fundamental
  • Price
  • CDNA $18.92
  • RES $5.31
  • Analyst Decision
  • CDNA Buy
  • RES Sell
  • Analyst Count
  • CDNA 8
  • RES 3
  • Target Price
  • CDNA $29.43
  • RES $6.17
  • AVG Volume (30 Days)
  • CDNA 912.4K
  • RES 1.5M
  • Earning Date
  • CDNA 05-08-2025
  • RES 04-24-2025
  • Dividend Yield
  • CDNA N/A
  • RES 3.03%
  • EPS Growth
  • CDNA N/A
  • RES N/A
  • EPS
  • CDNA 0.93
  • RES 0.43
  • Revenue
  • CDNA $333,785,000.00
  • RES $1,414,999,000.00
  • Revenue This Year
  • CDNA $13.32
  • RES N/A
  • Revenue Next Year
  • CDNA $14.99
  • RES $7.19
  • P/E Ratio
  • CDNA $20.44
  • RES $12.55
  • Revenue Growth
  • CDNA 19.07
  • RES N/A
  • 52 Week Low
  • CDNA $7.42
  • RES $5.04
  • 52 Week High
  • CDNA $34.84
  • RES $8.19
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 36.93
  • RES 35.42
  • Support Level
  • CDNA $17.73
  • RES $5.04
  • Resistance Level
  • CDNA $22.61
  • RES $5.59
  • Average True Range (ATR)
  • CDNA 1.31
  • RES 0.25
  • MACD
  • CDNA -0.35
  • RES -0.02
  • Stochastic Oscillator
  • CDNA 18.97
  • RES 23.68

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment consists of pressure pumping, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, and fishing. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.

Share on Social Networks: